Building upon continued success, company offers new platform for general
SUNNYVALE, Calif., Oct. 10 /PRNewswire/ -- Starion Instruments, a leading surgical device company, launched the TLS3 Tissue Ligating Shears at the American College of Surgeons 93rd Annual Clinical Congress in New Orleans this week. With the introduction of this new platform, Starion is building upon its success in the cardiovascular and otolaryngological markets to provide an essential solution for general surgical, gynecological and urological procedures.
Unlike conventional products that use monopolar, bipolar or ultrasonic energy as modes of operation, the TLS3 features Starion's proprietary tissue welding technology, which focuses thermal energy to simultaneously seal and divide soft tissue. This reduces thermal spread, which minimizes the risk of inadvertent collateral damage.
"Since the response to our technology by cardiovascular and otolaryngological surgeons has been extremely positive, we've taken this step to expand into the general surgical, gynecological and urological spaces," said Kirt Kirtland, president and chief executive officer of Starion Instruments. "With the TLS3, Starion now offers a complete platform that provides surgeons with the power and precision to quickly and effectively perform a variety of surgical procedures."
The TLS3 features enhanced sealing and dissecting capabilities, an ergonomic handle design, longer more tapered jaws, and two-speed finger control for unparalleled performance in open and minimally invasive surgical procedures. Three lengths, 14cm, 23cm and 35cm, provide improved sealing and dividing of larger vessels frequently encountered in general surgical, gynecological and urological procedures. Along with the TLS3, Starion is introducing a new Universal Power Supply that is compatible with the company's entire product line.
"The Starion TLS3 is the most versatile
|SOURCE Starion Instruments|
Copyright©2007 PR Newswire.
All rights reserved